Healthequity (NASDAQ:HQY) Issues Quarterly Earnings Results, Beats Expectations By $0.33 EPS

Healthequity (NASDAQ:HQY) posted its earnings results on Tuesday. The company reported $0.47 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.14 by $0.33, reports. Healthequity had a return on equity of 11.77% and a net margin of 28.13%. The firm had revenue of $157.12 million for the quarter, compared to analyst estimates of $152.38 million. During the same period in the previous year, the company posted $0.25 earnings per share. The company’s revenue for the quarter was up 122.9% on a year-over-year basis. Healthequity updated its FY 2020
After-Hours guidance to 1.46-1.52 EPS.

NASDAQ:HQY opened at $61.24 on Wednesday. The company has a market capitalization of $4.44 billion, a P/E ratio of 64.46, a P/E/G ratio of 2.87 and a beta of 1.47. The business has a fifty day simple moving average of $59.78 and a two-hundred day simple moving average of $64.21. The company has a debt-to-equity ratio of 0.04, a current ratio of 22.98 and a quick ratio of 22.98. Healthequity has a 1 year low of $50.29 and a 1 year high of $91.19.

Several equities analysts recently issued reports on HQY shares. Zacks Investment Research upgraded Healthequity from a “sell” rating to a “buy” rating and set a $62.00 price objective for the company in a research report on Tuesday, November 5th. Raymond James raised shares of Healthequity from an “outperform” rating to a “strong-buy” rating and cut their price target for the company from $90.00 to $80.00 in a research note on Monday, September 9th. Wells Fargo & Co cut their price target on shares of Healthequity from $80.00 to $76.00 and set an “outperformer” rating on the stock in a research note on Wednesday, September 4th. Barrington Research reiterated a “buy” rating and issued a $75.00 price target on shares of Healthequity in a report on Monday. Finally, Oppenheimer lowered their price objective on shares of Healthequity from $98.00 to $76.00 and set an “outperform” rating for the company in a research report on Wednesday, September 4th. Three equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. Healthequity has an average rating of “Buy” and an average price target of $77.00.

In other Healthequity news, CFO Darcy G. Mott sold 4,000 shares of the company’s stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $61.61, for a total transaction of $246,440.00. Following the sale, the chief financial officer now directly owns 46,000 shares of the company’s stock, valued at $2,834,060. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Over the last 90 days, insiders sold 12,000 shares of company stock worth $715,600. Corporate insiders own 3.70% of the company’s stock.

About Healthequity

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Story: What are no-load funds?

Earnings History for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with's FREE daily email newsletter.